Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to collect clinical data to evaluate the safety and performance of ESTYME® MATRIX Round microtextured breast implants in patients who receive these silicone gel-filled implants as part of their breast augmentation surgery in primary intention. This study also aims to measure patient and surgeon satisfaction. An initial study of all ESTYME® MATRIX implants was conducted between 2018 and 2021. The purpose of the current EMMA study is to complete the data from this first study on a larger number of implants, and only on the ESTYME® MATRIX Round Microtextured Silicone Gel-Filled Breast Implants range for primary intention breast augmentation, with a view to obtaining marketing authorization (CE marking).


Clinical Trial Description

n/a


Study Design


NCT number NCT05336526
Study type Interventional
Source Symatese Aesthetics
Contact Adeline BECHET
Phone 03 44 89 85 84
Email a.bechet@symatese.com
Status Recruiting
Phase N/A
Start date March 18, 2022
Completion date August 2024